These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
527 related items for PubMed ID: 19172274
1. Risk factors for poor treatment outcome and central nervous system relapse in diffuse large B-cell lymphoma with bone marrow involvement. Lee KW, Yi J, Choi IS, Kim JH, Bang SM, Kim DW, Im SA, Kim TY, Yoon SS, Lee JS, Bang YJ, Park S, Kim BK, Cho HI, Heo DS. Ann Hematol; 2009 Sep; 88(9):829-38. PubMed ID: 19172274 [Abstract] [Full Text] [Related]
2. Central nervous system involvement in diffuse large B-cell lymphoma. Yamamoto W, Tomita N, Watanabe R, Hattori Y, Nakajima Y, Hyo R, Hashimoto C, Motomura S, Ishigatsubo Y. Eur J Haematol; 2010 Jul; 85(1):6-10. PubMed ID: 20236301 [Abstract] [Full Text] [Related]
3. Central nervous system (CNS) relapse in diffuse large B cell lymphoma (DLBCL): pre- and post-rituximab. Tai WM, Chung J, Tang PL, Koo YX, Hou X, Tay KW, Quek R, Tao M, Lim ST. Ann Hematol; 2011 Jul; 90(7):809-18. PubMed ID: 21229246 [Abstract] [Full Text] [Related]
7. Central nervous system recurrence in adult patients with acute lymphoblastic leukemia: frequency and prognosis in 467 patients without cranial irradiation for prophylaxis. Sancho JM, Ribera JM, Oriol A, Hernandez-Rivas JM, Rivas C, Bethencourt C, Parody R, Deben G, Bello JL, Feliu E, Programa para el Estudio y Tratamiento de Hemopatias Malignas Group. Cancer; 2006 Jun 15; 106(12):2540-6. PubMed ID: 16700036 [Abstract] [Full Text] [Related]
13. Absolute lymphocyte count at the time of first relapse predicts survival in patients with diffuse large B-cell lymphoma. Porrata LF, Ristow K, Habermann TM, Witzig TE, Inwards DJ, Markovic SN. Am J Hematol; 2009 Feb 20; 84(2):93-7. PubMed ID: 19123458 [Abstract] [Full Text] [Related]
14. [Dose-intensive immunochemotherapy with or without autologous hematopoietic stem cell transplantation in the treatment of 29 newly diagnosed young patients with medium/high risk diffuse large B-cell lymphoma]. Yi S, Liu W, Lyu R, Li Z, Xu Y, Sui W, Huang W, Wang T, Deng S, Liu H, Fu M, Zou D, Qiu L. Zhonghua Xue Ye Xue Za Zhi; 2014 Jun 20; 35(6):546-50. PubMed ID: 24985182 [Abstract] [Full Text] [Related]
18. [Treatment strategy for central nervous system involvement in intravascular large B-cell lymphoma]. Shimada K. Brain Nerve; 2011 May 20; 63(5):467-72. PubMed ID: 21515926 [Abstract] [Full Text] [Related]
19. Reassessment of the prognostic factors of international prognostic index (IPI) in the patients with diffuse large B-cell lymphoma in an era of R-CHOP in Chinese population. Yang S, Yu Y, Jun-Min L, Jian-Qing M, Qiu-Sheng C, Yu C, Wei-Li Z, Jian-Hua Y, Hui-Jin Z, Yan W, Li W, Shu C, Zhi-Xiang S. Ann Hematol; 2009 Sep 20; 88(9):863-9. PubMed ID: 19205655 [Abstract] [Full Text] [Related]
20. Comparison of peripheral T-cell lymphomas and diffuse large B-cell lymphoma. Tomita N, Motomura S, Hyo R, Takasaki H, Takemura S, Taguchi J, Fujisawa S, Ogawa K, Ishigatsubo Y, Takeuchi K. Cancer; 2007 Mar 15; 109(6):1146-51. PubMed ID: 17311304 [Abstract] [Full Text] [Related] Page: [Next] [New Search]